Archives
-
LRRC8A–CAV1 Signaling Drives PDAC Growth
2026-09-17
The reference study identifies a cholesterol-dependent LRRC8A–CAV1 complex that links cell-volume regulation with KRAS/EGFR signaling, ribosome biogenesis, protein synthesis, and pancreatic ductal adenocarcinoma growth. Its combination of genetic, pharmacological, proteomic, xenograft, and patient-derived organoid models provides a useful framework for testing how membrane organization supports biosynthetic expansion in PDAC.
-
H 89 2HCl for cAMP/PKA Assays
2026-09-17
H 89 2HCl provides a practical pharmacological switch for testing whether cAMP-driven phosphorylation, neurite remodeling, or mechanosensory sensitization depends on PKA activity. This guide combines concentration-aware workflows with controls that help distinguish PKA effects from the compound’s broader kinase inhibition profile.
-
O-propargyl-puromycin (OPP) for B-Cell Translation
2026-09-16
O-propargyl-puromycin (OPP) converts a short translation pulse into a measurable signal for comparing global protein synthesis across B-cell states. Its click-chemistry readout complements mitochondrial, immunoglobulin, and phenotype assays, enabling single-cell analysis as well as proteomics workflows.
-
Verbascoside at the PKC/NF-κB Pain-Bone Interface
2026-09-16
Verbascoside offers a mechanistically focused way to interrogate PKC/NF-κB signaling across osteoclastogenesis and inflammatory pain biology. This thought-leadership framework connects RANKL-driven bone remodeling with trigeminal-ganglion findings while defining a practical, evidence-aware path for translational validation.
-
BMAL1–STAT6 Control of Endothelial Apoptosis
2026-09-15
The reference study identifies BMAL1 as an anti-apoptotic regulator in endothelial cells and links this activity to transcriptional repression of STAT6. Using endothelial Bmal1 manipulation, an alkali-burn corneal neovascularization model, proteomics, rescue experiments, and promoter analysis, the authors define a BMAL1–STAT6 pathway with implications for understanding pathological angiogenesis.
-
Native Protein Gel Electrophoresis in CF Research
2026-09-15
Discover how native protein gel electrophoresis can complement functional cystic fibrosis models by preserving protein state during biochemical analysis. This guide explains the K4142 workflow, assay boundaries, and how to interpret native PAGE alongside iPSC-derived airway readouts.
-
HRP Goat Anti-Rabbit IgG: From Signal to Evidence
2026-09-14
Discover how Affinity-Purified Goat Anti-Rabbit IgG (H+L) supports rigorous Western blot, ELISA, and immunohistochemistry workflows. This article connects HRP-based signal generation with the evidence architecture used to investigate PSMD13 and immune features in hepatocellular carcinoma.
-
PP 2 (AG 1879): A Mechanistic Assay Guide
2026-09-14
PP 2 (AG 1879) is a selective Src-family kinase probe for connecting phosphorylation events with cell behavior. This guide applies the compound to cancer research, T cell signaling, and a new decidualization assay framework grounded in the PA–Src–FAK–RhoA/ROCK pathway.
-
N2703 in Adipose-Neural Cardiac Assays
2026-09-13
Explore how 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) can support causal assay design around adipose-neural signaling and cardiac electrophysiology. This article emphasizes controls, interpretation, and translational limitations rather than repeating a general pathway overview.
-
FPR2/ALX, Microglia, and Autoimmune Astrocytopathy
2026-09-12
This study identifies FPR2/ALX stimulation with Quin-C1 as a way to limit AQP4-IgG- and complement-driven astrocytopathy in mice by coordinating microglial and natural killer cell responses. Its depletion and kinase-inhibition experiments connect the protective phenotype to microglia, NK cells, and SYK-AKT signaling, while also defining important limits for translation to human NMOSD.
-
Sildenafil Citrate and the Proteoform Precision Shift
2026-09-11
Sildenafil Citrate offers a mechanistically defined route into cGMP biology, while native-membrane proteomics reveals why target selectivity must be evaluated at the proteoform level.
-
Bacitracin B1670: Practical Research Guide
2026-09-11
Bacitracin B1670 is a peptide antibiotic for controlled antibacterial research focused on bacterial cell wall and peptidoglycan synthesis disruption. This guide covers solvent selection, stock preparation, assay controls, storage, and interpretation boundaries; it is not intended for diagnostic, clinical, therapeutic, or other medical use.
-
Ginsenoside Rg2 and Alzheimer’s BBB Integrity
2026-09-10
The reference study shows that ginsenoside Rg2 can reduce astrocyte-driven inflammation and improve blood-brain barrier tightness in complementary mouse, endothelial-cell, astrocyte, and co-culture models of Alzheimer’s disease-related injury. Its main contribution is a mechanistic model linking reduced astrocyte activation and TLR4/MyD88/MMP9 signaling with preservation of endothelial tight junctions, while also identifying oxidative stress as a relevant pathway.
-
Oridonin Targets Inflammation in Esophageal Cancer
2026-09-10
Peng et al. report that oridonin attenuated esophageal lesions and inflammatory signaling in a 4-NQO-induced mouse model, with effects associated with suppression of the TLR4/NF-κB/NLRP3 inflammasome axis. The study links inflammatory pathway modulation with changes in proliferation, apoptosis, systemic blood indices, and tissue pathology, while also highlighting the need for mechanistic and translational validation.
-
Tariquidar: Decoding Mechanobiology-Driven Chemoresistance
2026-09-09
Tumor viscosity is emerging as a mechanobiological driver of P-glycoprotein upregulation and chemotherapy resistance. This article connects that finding to Tariquidar (XR9576), outlining how selective ABCB1 inhibition can distinguish transporter activity from upstream mechanical signaling and strengthen translational drug resistance research.